Abstract
The current study investigates the relation between age and emotional responses and coping strategies at two moments during the spread of COVID-19 in Poland, namely the first peak (March-May 2020) and the second pick (October-December 2020). A sample of 414 individuals between the ages of 18 and 81 were asked to rate the intensity of the ‘shock’, ‘sadness’, ‘anger’, and ‘fear’ they experienced due to COVID-19 and respond to items from the Brief Cope questionnaire. The present findings demonstrate that anger was consistently less intense among older adults than younger ones. Emotion-focused coping strategies were more commonly used by younger adults than middle-aged or older ones at the first peak of the outbreak; however, this trend had reversed during the second peak of the pandemic, as the older age groups demonstrated a far greater increase in the use of this form of coping. Results indicate a greater ability to use emotional regulation among older adults than younger ones, as the former are less likely to react to a crisis through anger and more able to adapt coping mechanisms to a dynamic environment.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
none
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The project was approved by the local ethics committee of the University of Economics and Social Sciences in Warsaw.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The raw data of this study are available from the corresponding author upon reasonable request.